Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells

Molecular and Cellular Biochemistry

Volumn 188, Issue 1-2, 1998, Pages 21-30

  Schwartz, Bertha ^a,b   Avivi Green, Carmel ^a   Polak Charcon, Sylvie ^c  

^a Inst of Biochem Food Sci Nutr

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Colon cancer; Cyclin kinase inhibitors; Cyclin kinases; Differentiation; Proliferation; Retinoblastoma

Indexed keywords

BUTYRIC ACID; PROTEIN P16; RETINOBLASTOMA PROTEIN; THYMIDINE KINASE;

CANCER CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; COLON CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; GENE REPRESSION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RNA PROBE;

ALKALINE PHOSPHATASE; BUTYRIC ACIDS; CELL DIFFERENTIATION; CELL DIVISION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; GROWTH SUBSTANCES; HUMANS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031727248     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006831330340     Document Type: Conference Paper

References (38)

1. Scheppach W, Bartram HP, Richter F: Role of short-chain fatty acids in the prevention of colorectal cancer. Eur J Cancer 31A: 1077-1080, 1995
2. Hague A, Butt AJ, Paraskeva C: The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? Proc Nut Soc 55: 937-943, 1996
3. Deng G, Liu G, Hu L, Gum JR, Kim YS: Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate. Cancer Res 52: 3378-3383, 1992
4. Kruh J, Tichonicky L, Defer N: Effect of butyrate on gene expression. In: HJ Binder, JH Cummings, K Soergel (eds.) Short Chain Fatty Acids. Dordrecht, Kluwer, pp 135-147, 1994
5. Gamet L, Daviaud D, Denis -Pouxviel C, Remesy C, Murat J-C: Effect of short-chain fatty acids on growth and differentiation of the human colon cancer cell line HT-29. Int J Cancer 52: 286-289, 1992
6. Gum JR, Kam JC, Hicks JW, Sleisenger MH, Kim YS: Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase. J Biol Chem 262: 1092-1097, 1987
7. Wiman KG: The retinoblastoma gene: role in cell cycle control and cell differentiation. Faseb J 7: 841-845, 1993
8. Riley DJ, Lee KY, Lee WH: The retinoblastoma protein: more than a tumor suppresor. Annu Rev Cell Biol 10: 1-29, 1995
9. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995
10. Bartek J, Bartkova J, Lukas J: The retinoblastoma protein pathway and the restriction point. Current Opin Cell Biol 8: 805-814, 1996
11. Gope R, Gope ML: Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer. Mol Cell Biochem 110: 123-133, 1992
12. Ali AA, Harvey JP, Wildrick DM, Roman BM: Retinoblastoma gene productassociated proteins in human colon cancer cell lines. Biochem Biophys Res Commun 194: 848-854, 1993
13. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1065, 1993
14. Hunter T, Pines J: Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994
15. Nigg EA: Cyclin-dependent protein kinases: Key regulators of the eukaryotic cell cycle. Bio Essays 17: 471-480, 1995
16. Resnitzky D, Reed SI: Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol Cell Biol 15: 3463-3469, 1995
17. Kranenburg O, Van der EB AJ, Zantema A: Cyclin D kinases and pRb: Regulators of the proliferation-differentiation switch. 367: 103-106, 1995
18. Tanaka EM, Gann AAF, Gates PB, Brockes JP: Newt myotubes reenter the cell cycle by phosphorylation of the retinoblastoma protein. J Cell Biol 136: 155-165, 1997
19. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995
20. Harper JW, Elledge SJ: Cdk inhibitors in development and cancer. Curr Opin Genet Dev 6: 56-64, 1996
21. Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O, Reznikoff C: Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res 55: 493-497, 1995
22. Ragione FD, Russo GL, Oliva A, Mercurio C, Mastropietro S, Pietra VD, Zappia V: Biochemical characterization of p16NK4- and p18-containing complexes in human cell lines. J Biol Chem 271: 15942-15949, 1996
23. Serrano M, Lee HW, Chin L, Cordon-Cardo C, Beach D, DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37, 1996
24. Schwartz B, Polak-Charcon S, Lamprecht SA, Niv Y, Kim YS: The induction of a differentiated phenotype in human colon cancer cells requires the attenuation of cytoskeletal tyrosine phosphorylation. Oncol Res 7: 277-287, 1995
25. Schwartz B, Avivi C, Lamprecht SA: Isolation and characterization of normal and neoplastic colonie epithelial cell populations. Gastro-enterology 100: 692-702, 1991
26. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Plwnica-Worms H, Huang CM, Livingston DM: The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58: 1085-1095, 1989
27. Lois AF Cooper LT, Geng Y, Nobori T, Carson D: Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Cancer Res 55: 4010-4013, 1995
28. Pinto M, Appay MD, Simon-Assman P, Cavalier G, Dracopoli X: Fogh J, et al.: Enterocytic differentiation in cultured human colon cancer cells by replacement of glucose by galactose in the medium. Biol Cell 44: 193-196, 1982
29. Zweibaum A, Pinto M, Chevalier G, Dussaulx E, Triadou N, Lacroix B, et al.: Enterocytic differentiation of a subpopulation of the human colon cancer cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 122: 21-29, 1985
30. Simons SK, Fuller SD: Cell surface polarity in epithelia. Ann Rev Cell Biol 1: 243-288, 1985
31. Rodriguez-Boulon E, Nelson WJ: Morphogenesis of the polarized epithelial cell phenotype. Science 245: 718-725, 1989
32. Cereijido M, Contreras RG, Gonzalez-Mariscal L: Development and alteration of polarity. Ann Rev Physiol 51: 585-595, 1989
33. Wang JYJ, Knudsen ES, Welch PJ: The retinoblastoma tumor suppressor protein. Adv Cancer Res 64: 25-85, 1994
34. Almasan A, Yin Y, Kelly RE, EP Lee, Bradley A, Li W, Bertino JR, Wahl GM: Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci 92: 5436-5440, 1995
35. Csordas A: On the biological role of histone acetylation. Biochem J 265: 23-38, 1990
36. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, et al.: Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci 91: 9700-9704, 1994
37. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S: Silencing of the E-cadherin invasion-suppressor gene by CpG methyl-ation in human carcinomas. Proc Natl Acad Sci 92: 7416-7419, 1995
38. Merlo A, Herman JG, Lee DJ, Gahrielson E, Burger PC, Baylin SB, Sidransky D: 5′-CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692, 1995